Pharma Equity Group A/S (CPH:PEG)
Denmark · Delayed Price · Currency is DKK 0.1200
+0.0015 (1.27%)
Jul 25, 2025, 4:59 PM CET
Pharma Equity Group Market Cap
Pharma Equity Group has a market cap or net worth of 147.31 million as of July 25, 2025. Its market cap has decreased by -49.65% in one year.
Market Cap
147.31M
Enterprise Value
154.12M
Revenue
n/a
Ranking
n/a
PE Ratio
n/a
Stock Price
0.12
Market Cap Chart
Since March 27, 2023, Pharma Equity Group's market cap has decreased from 767.22M to 147.31M, a decrease of -80.80%. That is a compound annual growth rate of -50.73%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 25, 2025 | 147.31M | -36.84% |
| Dec 30, 2024 | 233.24M | -46.98% |
| Dec 29, 2023 | 439.87M | -42.67% |
| Mar 27, 2023 | 767.22M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1,965.61B |
| Coloplast | 138.21B |
| Genmab | 89.15B |
| Demant | 58.62B |
| ALK-Abelló | 42.53B |
| H. Lundbeck | 32.67B |
| Ambu A/S | 26.77B |
| Zealand Pharma | 26.23B |